findmyKOL
Clinical trialNCT00774852CompletedPhase 2Interventional

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment137Lupus Erythematosus, SystemicLupus Nephritis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Mexico
  • Unidad de Investigación En Enfermedades Crónico - Degenerativas Sc

    Guadalajara, Jalisco, Mexico

  • El Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán (innsz)

    Mexico City, Mexico

United States
  • University of Alabama, Birmingham

    Birmingham, Alabama, United States

  • University of California San Diego

    La Jolla, California, United States

  • Cedars Sinai Medical Center

    Los Angeles, California, United States

  • University of California San Francisco

    San Francisco, California, United States

  • University of Miami

    Miami, Florida, United States

  • Emory University

    Atlanta, Georgia, United States

  • Rush University Medical Center

    Chicago, Illinois, United States

  • University of Chicago

    Chicago, Illinois, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Wayne State University

    Detroit, Michigan, United States

  • Feinstein Institute

    Manhasset, New York, United States

  • Columbia University

    New York, New York, United States

  • Seligman Center for Advanced Therapeutics (nyu)

    New York, New York, United States

  • University of Rochester

    Rochester, New York, United States

  • Unc Chapel Hill

    Chapel Hill, North Carolina, United States

  • Ohio State University Medical Center

    Columbus, Ohio, United States

  • Oklahoma Medical Research Foundation

    Oklahoma City, Oklahoma, United States

  • Temple University

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh Lupus Center of Excellence

    Pittsburgh, Pennsylvania, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • Ut Southwestern

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2008
Primary completion
31 Dec 2012
Completion
30 Jun 2014
Last update posted
8 Feb 2016
Registered enrollment
137
Registry id
NCT00774852

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.